Sudeep Pharma Limited IPO: Offer for Sale
Sudeep Pharma Limited has announced its Draft Red Herring Prospectus (DRHP) for an upcoming IPO. This IPO is primarily an Offer for Sale (OFS), presenting an opportunity for investors to participate in the growth story of a leading excipient and specialty ingredient manufacturer.
Company Overview
Sudeep Pharma is a technology-driven manufacturer specializing in excipients and specialty ingredients for the pharmaceutical, food, and nutrition industries. The company leverages in-house technologies like encapsulation, spray drying, and blending to drive innovation. With a global presence, Sudeep Pharma serves approximately 100 countries across key regions, including the United States, Europe, and Asia-Pacific.
The company operates through two main verticals: Pharmaceutical, food, and nutrition, focusing on refined, mineral-based single ingredients, and Specialty Ingredients, which produces customized ingredients to improve functionality and bioavailability. They operate three advanced manufacturing facilities in Vadodara, Gujarat, with a combined annual manufacturing capacity of 65,579 MT.
Key Achievements
Sudeep Pharma has demonstrated strong growth and established itself as a key player in its industry. Key highlights include:
- One of the largest producers of food-grade iron phosphate for infant nutrition.
- One of the largest exporters of mineral ingredients from India.
- Serving over 1,100 customers, including Pfizer Inc, Intas Pharmaceuticals Limited, and Danone S.A.
- Strong customer relationships with marquee clients.
Financial Overview (As of December 31, 2024)
Here s a snapshot of the company s financial performance:
| Financial Metric | Amount ( in Crores) |
|---|---|
| Total Assets | 656.92 |
| Net Worth | 449.72 |
| Reserves and Surplus | 437.75 |
| Total Borrowing | 117.19 |
Offer for Sale and IPO Structure
The IPO consists of both a fresh issue and an Offer for Sale (OFS). The OFS involves the sale of shares by the following shareholders:
- Mr. Sujit Jaysukh Bhayani
- Sujeet Jaysukh Bhayani HUF
- Mr. Shanil Sujit Bhayani
- Ms. Avani Sujit Bhayani
The allocation of shares for different investor categories is as follows:
- Retail Investors: 35%
- Qualified Institutional Buyers (QIB): 50%
- Non-Institutional Investors (NII): 15%
The shares of Sudeep Pharma Limited are proposed to be listed on the BSE and NSE.
Lead Managers and Registrar
The lead managers for the IPO are:
- Icici Securities Limited
- Iifl Capital Services Limited
The registrar for the IPO is:
- Mufg Intime India Private Limited
Conclusion
Sudeep Pharma’s IPO presents a promising investment opportunity in the growing excipient and specialty ingredient market. Investors are encouraged to stay updated on the IPO dates and other relevant details to make informed decisions. Keep an eye on this space for more updates on the Sudeep Pharma Limited IPO.